Skip to content

The effect of supplementation on the combined pill continuation rate and Harassment rate of its side effects

The effect of supplementation on the combined pill continuation rate and Harassment rate of its side effects: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201210093706N15
Enrollment
330
Registered
2012-12-09
Start date
2012-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

continuation rate of oral contraceptives. oral contraceptives

Interventions

Intervention 1: taking 7 multivitamins pills monthly during the 7 day no pill period for 6 months (each pill contains Vitamin A 5000 I.U. , Vitamin B1 1.5 mg , Vitamin B2 1.7 mg , Vitamin B6 2 mg , V
Prevention
taking 7 multivitamins pills monthly during the 7 day no pill period for 6 months (each pill contains Vitamin A 5000 I.U. , Vitamin B1 1.5 mg , Vitamin B2 1.7 mg , Vitamin B6 2 mg , VitaminC 60 mg ,
taking 7 placebo pills monthly during the 7 day no pill period for 6 months
No intervention (no pill taking on the 7 days interval between taking every cycle pills)

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 49 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: married no pregnant women aged 18-40 years; intention to start using Low dose (LD) combined pills as a contraceptive method; being literate; not taking combined hormonal methods at least in the past three months. Exclusion criteria: plan to get pregnant in 6 months; not having medical eligibility criteria for contraceptive use.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Continuation rate. Timepoint: monthly. Method of measurement: interview.;Harrasement rate of side effects of the pills. Timepoint: daily. Method of measurement: interview.

Secondary

MeasureTime frame
Correct use of the pills. Timepoint: monthly. Method of measurement: interview.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLaiya Forougi

Faculty of Nursing & Midwifery, Tabriz University of Medical Sciences

alizades@tbzmed.ac.ir+98 41 1479 7713

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026